Expanded Access to Antiviral Paxlovid for Severe COVID-19 Cases
In response to mounting concerns surrounding the Omicron variant, NICE has announced expanded access to Pfizer's antiviral drug Paxlovid, benefiting...
Access our range of useful resources here, including MaPPs, Choice and Medication & clinical guidelines
Filter: